·7 min read·buyers-guide
Singapore GLP-1 May 2026: MOH Circular 87/2024 one year on, Foundayo HSA outlook, oral Wegovy approval pathway
MOH Circular 87/2024 hit its one-year anniversary in March; the in-person-consultation rule is now observable, not theoretical. Foundayo (orforglipron) HSA pathway tracking 12-18 months behind FDA. Oral Wegovy 25mg HSA filing the more imminent question. What changed for SG readers since the April buyer's guide.